gst-hg131
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 18, 2020 (NCT04499443)
Timeline
Indications
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06263959 | Phase 2 | Dec 29, 2023 | Government of China |
| NCT04499443 | Phase 1 | Aug 18, 2020 | Fujian Cosunter Pharmaceutical Co. Ltd, Jilin University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fujian Cosunter Pharmaceutical Co. Ltd | For profit | 1 | 1 | 1 | 2020 |
| Government of China | Government | 1 | 1 | 1 | 2023 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1